Avience Biomedicals IPO Review: PAT Tripled, P/E at 10.91 & Full Analysis
Updated on 25.06.2026|10:00 AMAvience Biomedicals Limited is set to launch its Initial Public Offering (IPO). It is an Indian enterprise engaged in the manufacturing and trading of medical consumables such as In-Vitro Diagnostic (IVD) products, rapid test kits, and biochemistry reagents. The public issue will open for subscription on Thursday, June 18, 2026, and will close […]
Avience Biomedicals IPO Review: PAT Tripled, P/E at 10.91 & Full Analysis Read More »
